NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email David Sacks is supposed to be pushing the tech industry’s AI agenda in Washington. But lobbyists fear he could be derailing it nationwide.Read More
